BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9729280)

  • 1. Re-epithelialization of the rabbit cornea is regulated by opioid growth factor.
    Zagon IS; Sassani JW; McLaughlin PJ
    Brain Res; 1998 Aug; 803(1-2):61-8. PubMed ID: 9729280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reepithelialization of the human cornea is regulated by endogenous opioids.
    Zagon IS; Sassani JW; McLaughlin PJ
    Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):73-81. PubMed ID: 10634604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic keratopathy and treatment by modulation of the opioid growth factor (OGF)-OGF receptor (OGFr) axis with naltrexone: a review.
    McLaughlin PJ; Sassani JW; Klocek MS; Zagon IS
    Brain Res Bull; 2010 Feb; 81(2-3):236-47. PubMed ID: 19683562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-epithelialization of the rat cornea is accelerated by blockade of opioid receptors.
    Zagon IS; Sassani JW; McLaughlin PJ
    Brain Res; 1998 Jul; 798(1-2):254-60. PubMed ID: 9666142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homeostasis of ocular surface epithelium in the rat is regulated by opioid growth factor.
    Zagon IS; Sassani JW; Kane ER; McLaughlin PJ
    Brain Res; 1997 Jun; 759(1):92-102. PubMed ID: 9219867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conserved expression of the opioid growth factor, [Met5]enkephalin, and the zeta (zeta) opioid receptor in vertebrate cornea.
    Zagon IS; Sassani JW; Allison G; McLaughlin PJ
    Brain Res; 1995 Feb; 671(1):105-11. PubMed ID: 7728521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid growth factor and organ development in rat and human embryos.
    Zagon IS; Wu Y; McLaughlin PJ
    Brain Res; 1999 Aug; 839(2):313-22. PubMed ID: 10519055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The opioid growth factor-opioid growth factor receptor axis: homeostatic regulator of cell proliferation and its implications for health and disease.
    McLaughlin PJ; Zagon IS
    Biochem Pharmacol; 2012 Sep; 84(6):746-55. PubMed ID: 22687282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The opioid growth factor, [Met5]-enkephalin, inhibits DNA synthesis during recornification of mouse tail skin.
    Wilson RP; McLaughlin PJ; Lang CM; Zagon IS
    Cell Prolif; 2000 Apr; 33(2):63-73. PubMed ID: 10845251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid growth factor inhibits intimal hyperplasia in balloon-injured rat carotid artery.
    Zagon IS; Essis FM; Verderame MF; Healy DA; Atnip RG; McLaughlin PJ
    J Vasc Surg; 2003 Mar; 37(3):636-43. PubMed ID: 12618704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid growth factor modulates corneal epithelial outgrowth in tissue culture.
    Zagon IS; Sassani JW; McLaughlin PJ
    Am J Physiol; 1995 Apr; 268(4 Pt 2):R942-50. PubMed ID: 7733405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The opioid growth factor, [Met5]-enkephalin, and the zeta opioid receptor are present in human and mouse skin and tonically act to inhibit DNA synthesis in the epidermis.
    Zagon IS; Wu Y; McLaughlin PJ
    J Invest Dermatol; 1996 Mar; 106(3):490-7. PubMed ID: 8648182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the opioid growth factor, [Met5]-enkephalin, and the zeta opioid receptor in head and neck squamous cell carcinoma.
    Levin RJ; Wu Y; McLaughlin PJ; Zagon IS
    Laryngoscope; 1997 Mar; 107(3):335-9. PubMed ID: 9121309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective blockade of the OGF-OGFr pathway by naltrexone accelerates fibroblast proliferation and wound healing.
    Immonen JA; Zagon IS; McLaughlin PJ
    Exp Biol Med (Maywood); 2014 Oct; 239(10):1300-9. PubMed ID: 25030485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naltrexone, an opioid antagonist, facilitates reepithelialization of the cornea in diabetic rat.
    Zagon IS; Jenkins JB; Sassani JW; Wylie JD; Ruth TB; Fry JL; Lang CM; McLaughlin PJ
    Diabetes; 2002 Oct; 51(10):3055-62. PubMed ID: 12351447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid growth factor modulation of corneal epithelium: uppers and downers.
    Sassani JW; Zagon IS; McLaughlin PJ
    Curr Eye Res; 2003 May; 26(5):249-62. PubMed ID: 12854052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The autocrine derivation of the opioid growth factor, [Met5]-enkephalin, in ocular surface epithelium.
    Zagon IS; Sassani JW; Wu Y; McLaughlin PJ
    Brain Res; 1998 May; 792(1):72-8. PubMed ID: 9593829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid growth factor is present in human and mouse gastrointestinal tract and inhibits DNA synthesis.
    Zagon IS; Wu Y; McLaughlin PJ
    Am J Physiol; 1997 Apr; 272(4 Pt 2):R1094-104. PubMed ID: 9140007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of OGFr delays the onset and reduces the severity of diabetic ocular surface complications.
    Zagon IS; Sassani JW; Purushothaman I; McLaughlin PJ
    Exp Biol Med (Maywood); 2021 Mar; 246(5):629-636. PubMed ID: 33203224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human renal cell cancer proliferation in tissue culture is tonically inhibited by opioid growth factor.
    Bisignani GJ; McLaughlin PJ; Ordille SD; Beltz MS; Jarowenko MV; Zagon IS
    J Urol; 1999 Dec; 162(6):2186-91. PubMed ID: 10569617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.